Clinical Trial Update: DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluated the DOT Diary App to optimize measurement of PrEP adherence and posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Snippet

Sponsor: Public Health Foundation Enterprises, Inc. | Conditions: Adherence, Medication, Risk Behavior | Phase 4 | Status: COMPLETED | Results posted: 2020-02-19